Folic acid supplementation in end-stage renal disease patients reduces total mortality rate

2013 ◽  
Vol 26 (6) ◽  
pp. 1097-1104 ◽  
Author(s):  
Shu-Chen Chien ◽  
Szu-Yuan Li ◽  
Yung-Tai Chen ◽  
Lung-Wen Tsai ◽  
Tzeng-Ji Chen ◽  
...  
Keyword(s):  
Folic Acid ◽  
Mortality Rate ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Total Mortality ◽  
Folic Acid Supplementation ◽  
Acid Supplementation ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Epidemiology of dialysis-treated end-stage renal disease patients in Kazakhstan: data from nationwide large-scale registry 2014–2018

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Abduzhappar Gaipov ◽  
Alpamys Issanov ◽  
Kainar Kadyrzhanuly ◽  
Dinara Galiyeva ◽  
Marina Khvan ◽  
...  
Keyword(s):  
Mortality Rate ◽  
Renal Disease ◽  
Survival Probability ◽  
End Stage Renal Disease ◽  
Older Patients ◽  
Large Scale ◽  
Dialysis Patients ◽  
Risk Of Death ◽  
Stage Renal Disease ◽  
End Stage

Abstract Background The epidemiology of dialysis patients has been little studied in developing countries and economies in transition. We examined the prevalence, incidence and mortality rate of dialysis patients in Kazakhstan, via aggregation and utilization of large-scale administrative healthcare data. Methods The registry data of 8898 patients receiving dialysis therapy between 2014 and 2018 years were extracted from the Unified National Electronic Health System (UNEHS) and linked with the national population registry of Kazakhstan. We provide descriptive statistics of demographic, comorbidity and dialysis-related characteristics. Results Among all patients undergoing maintenance dialysis for end-stage renal disease (ESRD), there were 3941 (44%) females and 4957 (56%) males. 98.7% of patients received hemodialysis and 1.3% peritoneal dialysis. The majority of the patients (63%) were ethnic Kazakhs, 18% were Russians and 19% were of other ethnicities. The prevalence and incidence rate in 2014 were 135.2 and 68.9 per million population (PMP), respectively, which were different in 2018 [350.2 and 94.9 PMP, respectively]. Overall mortality rate among dialysis patients reduced from 1667/1000 patient-years [95%Confidence Interval (CI): 1473–1886] (PY) in 2014 to 710/1000PY [95%CI: 658–767] in 2018. We observed 13% lower crude survival probability in females compared to males and in older patients compared to younger ones. Russian ethnicity had 58% higher risk of death, while other ethnicities had 34% higher risk of death compared to in those of Kazakh ethnicity. Conclusion We describe for the first time in Kazakhstan an increase in the prevalence and incidence of ESRD on dialysis, while mortality rate decreased over time, during 2014–2018. We observed statistically significant lower survival probability in female dialysis patients compared to males, in older patients compared to younger ones, and in patients of Russian ethnicity compared to Kazakh.

scholarly journals B Vitamins and the Risk of Total Mortality and Cardiovascular Disease in End-Stage Renal Disease

Circulation ◽  
2010 ◽  
Vol 121 (12) ◽  
pp. 1432-1438 ◽  
Author(s):  
Judith Heinz ◽  
Siegfried Kropf ◽  
Ute Domröse ◽  
Sabine Westphal ◽  
Katrin Borucki ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Total Mortality ◽  
B Vitamins ◽  
Stage Renal Disease ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document